SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Johnny Cash — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJohnny Cash
Date of birth1932-02-26
IdentifiersMRN HR-ML004-SYN-TD; SSN (made up) 000-04-8125
Document date2003-03-27
AuthorGideon Hale, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Endocrinology consultation and four-week diabetes check: lightheadedness on standing and choice of add-on glucose-lowering therapy. [S]

History of Present Illness

Mr. Cash is a 71-year-old man with type 2 diabetes, autonomic and peripheral neuropathy, and severe primary open-angle glaucoma, seen four weeks after his first visit for an endocrinology consultation on the same day as his diabetes check. Metformin was raised to 1000 mg twice daily, atorvastatin was started, and dorzolamide was added to latanoprost four weeks ago. He takes all of them, and metformin causes no stomach upset. His fasting home glucose readings run 140 to 170 mg/dL, with none below 70. He now stands up in stages, has raised the head of his bed, wears waist-high compression, and drinks about 2 liters a day. He is still lightheaded on standing most mornings and after meals, but he has had no further falls since the first visit. He asks again what he really has, since he was once told it was Shy-Drager syndrome. [S]

ElementDetail
Interval changeLightheaded on standing most mornings and after meals; no further falls
Medication toleranceNo stomach upset on metformin 1000 mg twice daily; no muscle aches on atorvastatin; no eye stinging on dorzolamide
Home glucoseFasting 140 to 170 mg/dL; none below 70
Non-drug measuresStaged standing, head of bed raised, waist-high compression, 2 liters of fluid a day
Patient questionWhat is causing the lightheadedness

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight down 1 kg; no fever
CardiovascularPositiveLightheaded on standing, worse in the morning and after meals; no fainting, chest pain, or palpitations
GastrointestinalNegativeNo nausea, diarrhea, or early fullness
GenitourinaryNegativeNo difficulty passing urine
NeurologicalPositiveNumb feet to the ankles, unchanged; weak legs
EndocrineNegativeNo shakiness, sweating, or confusion suggesting low glucose

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 500 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet by mouth twice daily with mealsOral route2001-05-06 to 2003-02-27completedS
Metformin 1000 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet by mouth twice daily with mealsOral route2003-02-27activeS
Sitagliptin 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2003-03-27activeS
Atorvastatin 40 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2003-02-27activeS
Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtimeOne drop in each eye at bedtimeOphthalmic route2000-09-11activeS
Dorzolamide 2% ophthalmic solution, one drop in each eye twice dailyOne drop in each eye twice dailyOphthalmic route2003-02-27activeS
Midodrine 2.5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PMOne tablet by mouth on waking, at midday, and mid-afternoon; last dose at least four hours before bedOral route2003-03-27 to 2003-05-29completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2003-03-27Body height188cmS
2003-03-27Body weight95kgS
2003-03-27Body mass index (BMI) [Ratio]26.9kg/m2S
2003-03-27Systolic blood pressure142mm[Hg]S
2003-03-27Diastolic blood pressure78mm[Hg]S
2003-03-27Heart rate76/minS
2003-03-27Respiratory rate16/minS
2003-03-27Body temperature36.6CelS
2003-03-27Oxygen saturation in Arterial blood by Pulse oximetry95%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2003-03-27Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2003-03-27Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2003-03-27Creatinine [Mass/volume] in Serum or Plasma1.06mg/dL0.74-1.35 mg/dLNormalS
2003-03-27Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M72mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2003-03-27Glucose [Mass/volume] in Serum or Plasma152mg/dL70-99 mg/dLHighS

Physical Exam

Vital signs recorded on 2003-03-27; see the Vital Signs section. [S]

SystemFinding
GeneralAlert and wry; walks in with a cane
CardiovascularRegular rhythm; blood pressure 150/84 mmHg lying, 142/78 mmHg seated, and 110/68 mmHg after three minutes standing, with heart rate 76 rising only to 80, and lightheadedness
FeetSkin intact; no ulcers or calluses; monofilament and vibration sensation reduced to the ankles; pedal pulses present
NeurologicalReduced ankle reflexes; stocking sensory loss in both legs

Problems

ProblemClinical statusVerificationCodeProvenance
Type 2 diabetes mellitus with diabetic autonomic neuropathy; HbA1c above the individualized goal at intakeactiveconfirmed E11.43S — Synthetic modern diagnosis linked to the publicly reported diabetes and autonomic neuropathy.
Neurogenic orthostatic hypotension from diabetic autonomic neuropathyactiveconfirmed I95.1S — Synthetic finding; explains the autonomic symptoms once labeled Shy-Drager syndrome.
Diabetic distal symmetric polyneuropathy with loss of protective sensation in both feetactiveconfirmed E11.42S — Synthetic finding linked to his description of numb lower extremities.
Primary open-angle glaucoma, both eyes, severe stageactiveconfirmed H40.1133S — Synthetic modern diagnosis; the type and stage are not documented historically.
Mild nonproliferative diabetic retinopathy without macular edema, both eyesactiveconfirmed E11.3293S — Synthetic finding from the dilated eye examination.
Hyperlipidemiaactiveconfirmed E78.5S — Synthetic finding from the baseline LDL cholesterol.
History of recurrent pneumoniaactiveconfirmed Z87.01S — Synthetic modern coding of the documented recurrent pneumonia; supports pneumococcal vaccination.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryBasic metabolic panelBefore choosing add-on therapy; yearly when eGFR is 60 or moreCompleted todayeGFR 72 and potassium 4.3: no dose change needed for metformin or sitagliptin, and safe to start midodrine
LaboratoryHbA1cEvery 3 months until at goal or after a therapy change; every 6 months when stableUp to date8.6% four weeks ago; next at the three-month review
LaboratoryLipid panel after starting a statin4 to 12 weeks after a statin starts or changesDueAtorvastatin started four weeks ago; draw within the next eight weeks
ExaminationBlood pressure, weight, and BMIEvery visitCompleted todaySeated 142/78 mmHg; weight 95.0 kg, down 1 kg
ExaminationLying, seated, and standing blood pressureEvery visitCompleted todayLying 150/84, standing 110/68 mmHg; heart rate 76 to 80. Baseline before midodrine
ExaminationFoot examination (inspection, pulses, monofilament)Every visit with loss of protective sensationCompleted todayNo ulcer; sensory loss unchanged
ExaminationTonometry (eye pressure)Every glaucoma visit; 4 to 6 weeks after adding a dropDeferredNot measured at this visit, and no eye-clinic check has been booked since dorzolamide was added four weeks ago, a deviation from the plan. Request sent to the eye clinic
SurveyHypoglycemia review and home glucose logEvery visitCompleted todayNo readings below 70 mg/dL and no symptoms of low glucose
SurveyTobacco useEvery visitCompleted todayNo tobacco use
Medication safetyMetformin, atorvastatin, and dorzolamide toleranceAfter each start or dose changeCompleted todayNo stomach upset, muscle aches, or eye stinging
Medication safetyAntihypertensive and other medicines that lower standing pressureEvery visit with orthostatic hypotensionCompleted todayNone in use; timolol and brimonidine avoided
ReferralEndocrinology consultationWhen the diagnosis or treatment of a complication is uncertainCompleted todaySeen today: diabetic autonomic neuropathy confirmed as the working diagnosis, sitagliptin and midodrine started
Self-managementOrthostatic hypotension measures and foot self-careEvery visitCompleted todayStaged standing, head-of-bed elevation, compression, fluids, and daily foot checks reviewed

Goal progress:

Guideline basis: Standards of Care in Diabetes—2025 (2025); Primary Open-Angle Glaucoma Preferred Practice Pattern (2025); CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs (2026)

Follow-up: Annual wellness visit in four weeks. Three-month review with HbA1c, lipids, and an eye pressure check. Next scheduled visit 2003-04-24: subsequent annual wellness visit. [S]